Clinical Trials
46 trialsWeCan-Rural
Duke University
A Synthetic Lethality-Focused Algorithm to Identify Therapeutic Options in Advanced Metastatic Breast Cancer (SYNTHESIS-Breast)
National Institutes of Health Clinical Center (CC)
Biospecimen Collection in Identifying Genetic Changes in Patients With Breast, Prostate, Colorectal, Liver, or Kidney Cancer or Multiple Myeloma Undergoing Surgery
National Cancer Institute (NCI)
The PhOCus Trial: Implementation of Pharmacogenomic Testing in Oncology Care
University of Chicago
COSMOPOLITAN
University Hospital Heidelberg
The Impact of Surgeon-Interpreted Intraoperative Margin Assessment During Breast Conserving Surgery on Postoperative Treatment
M.D. Anderson Cancer Center
Finding an Effective Dose of GM1 to Reduce or Prevent Neuropathy (Numbness or Weakness) Due to Treatment With Paclitaxel (Phase II)
Alliance for Clinical Trials in Oncology
Paclitaxel Therapeutic Drug Monitoring in Cancer Patients
Wake Forest University Health Sciences
Hypofractionated Partial Breast Irradiation in Treating Patients With Early Stage Breast Cancer
M.D. Anderson Cancer Center
Atezolizumab Plus Tivozanib in Immunologically Cold Tumor Types
University of Florida
CRYOMATASE
University Hospital, Montpellier
Pilot Trial of Preop Partial Radiation in Breast Cancer Patients
Rutgers, The State University of New Jersey
Genetic Testing to Improve Management of Patients Undergoing Breast Biopsy
Mayo Clinic
MIRROR
University of California, San Francisco
Physiotherapy Program Impact on Breast Cancer-Related Lymphedema
European University Miguel de Cervantes
Adherence Intervention in Patients With Metastatic Breast Cancer
Columbia University
Optimizing Treatment of Stage IV Breast Cancer Through Real-Time Disease Monitoring
Mayo Clinic
IPT
New York State Psychiatric Institute
Taletrectinib in Previously Treated Metastatic CDH1-mutated Invasive Lobular Cancer (ILC)
Case Comprehensive Cancer Center
Postoperative Identification of Tumor Cells At the Lumpectomy Site of Patients with Early Breast Cancer
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
RNSM
University Health Network, Toronto
Multiparametric MRI as a Non-Invasive Biomarker of the Tumor Microenviroment
Vanderbilt-Ingram Cancer Center
Eribulin Mesylate or Paclitaxel as First- or Second-Line Therapy in Treating Patients With Recurrent Stage IIIC-IV Breast Cancer
Academic and Community Cancer Research United
A Study to Investigate the Safety, Tolerability, of APG-2575 as a Single Agent or in Combination for Breast Cancer
Ascentage Pharma Group Inc.
Alpha-TEA and Trastuzumab for the Treatment of Refractory HER2+ Metastatic Breast Cancer
Veana Therapeutics
Diffusion-Weighted MRI for Breast Cancer Screening in Women With a Personal History of Breast Cancer
Seoul National University Hospital
DNX-2440 for Resectable Colorectal Liver Metastasis
DNAtrix, Inc.
Safety and Activity Study of HER2-Targeted Dual Switch CAR-T Cells (BPX-603) in Subjects With HER2-Positive Solid Tumors
Bellicum Pharmaceuticals
Guangzhou Women's Health Cohort Study (GWHCS)
Guangzhou Women and Children's Medical Center
Comparison of Two Types of Biopsy in Suspicious Axillary Lymph Nodes
Peking University People's Hospital
Short and Long Term Effects of a Physical Therapy Program After Breast Cancer Surgery
Universidade Federal de Sao Carlos
Trial of Neoadjuvant Docetaxel ± Metronomic Capecitabine/CTX Followed by FEC in Women With Operable Triple Negative Breast Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Real-time Diagnosis and Visualization of Tumor Margins in Excised Breast Specimens Using Zenith FLIM Diagnostics
Laser LabCorp
Predicting Response of Metastatic Triple Negative Breast Cancer to Immunotherapy Based on Patients Cytokine Profile
Texas Tech University Health Sciences Center, El Paso
Pre-operative Hormonal Treatment for Hormone Receptor Positive Breast Cancer
The Netherlands Cancer Institute
Guide for Prioritisation of Patients for Referral to Breast Clinics
The Leeds Teaching Hospitals NHS Trust
Clinical Evaluation of Opto-Acoustic Image Quality With the Gen1B Duplex Probe in Breast Applications
Seno Medical Instruments Inc.
Computed Optical Margin Assessment for Breast Cancer Surgery, Phase I (Part B)
Diagnostic Photonics, Inc.
ANCERS-2
Mitra RxDx, Inc.
Thermalogical Analysis of a Cohort of Women and Men Undergoing Mammographic Analysis.
First Sense Medical, LLC
Trial of 2nd Generation Anti-CEA Designer T Cells in Metastatic Breast Cancer
Roger Williams Medical Center
YoungWomen
National Guard Health Affairs
Early Predictor of Herceptin Cardio Toxicity in Breast Cancer Patients
National Guard Health Affairs
Combination Chemotherapy in Treating Women With Stage III Breast Cancer
National Cancer Institute (NCI)
Vaginal Testosterone Cream For Atrophic Vaginitis in Women Taking Aromatase Inhibitors for Breast Cancer.
University of Vermont
Safety and Effectiveness Study of Autologous Natural Killer and Natural Killer T Cells on Cancer
Envita Medical Center, Inc.